13 of the 21 members of the SGE LSD attended the teleconference organised on 25 February 2019. The possible vaccine availability and supply needs were expressed by each participant and acknowledged by the European Commission as regards requests to be covered by the EU vaccine bank and/or possible reimbursement for the cost of vaccines purchased through national funds.
The European Commission can also provide support for surveillance where vaccination has ceased or is reduced in the framework of the vaccination exit strategy. Formal requests and relevant surveillance plans need to be submitted to the European Commission.